Literature DB >> 33949944

In patients with heart failure, enhanced ventilatory response to exercise is associated with severe obstructive sleep apnea.

Lia Bittencourt1, Shahrokh Javaheri2, Denise Maria Servantes1, Ana Claudia Pelissari Kravchychyn1, Dirceu Rodrigues Almeida3, Sérgio Tufik1.   

Abstract

STUDY
OBJECTIVES: Patients with congestive heart failure (CHF) frequently exhibit an elevated ratio of minute ventilation over CO2 output (VE/VCO2 slope) while undergoing exercise tests. One of the factors contributing to this elevated slope is an increased chemosensitivity to CO2 in that this slope significantly correlates with the slope of the ventilatory response to CO2 rebreathing at rest. A previous study in patients with CHF and central sleep apnea showed that the highest VE/VCO2 slope during exercise was associated with the most severe central sleep apnea. In the current study, we tested the hypothesis that in patients with CHF and obstructive sleep apnea (OSA), the highest VE/VCO2 slope is also associated with the most severe OSA. If the hypothesis is correct, then it implies that in CHF, augmented instability in the negative feedback system controlling breathing predisposes to both OSA and central sleep apnea.
METHODS: This preliminary study involved 70 patients with stable CHF and a spectrum of OSA severity who underwent full-night polysomnography, echocardiography, and cardiopulmonary exercise testing. Peak oxygen consumption and the VE/VCO2 slope were calculated.
RESULTS: There was significant positive correlation between the apnea-hypopnea index and the VE/VCO2 slope (r = .359; P = .002). In the regression model, involving the relevant variables of age, body mass index, sex, VE/VCO2 slope, peak oxygen consumption, and left ventricular ejection fraction, the apnea-hypopnea index retained significance with VE/VCO2.
CONCLUSIONS: In patients with CHF, the VE/VCO2 slope obtained during exercise correlates significantly to the severity of OSA, suggesting that an elevated CO2 response should increase suspicion for the presence of severe OSA, a treatable disorder that is potentially associated with excess mortality. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov; Name: Comparison Between Exercise Training and CPAP Treatment for Patients With Heart Failure and Sleep Apnea; URL: https://clinicaltrials.gov/ct2/show/record/NCT01538069; Identifier: NCT01538069. CITATION: Bittencourt L, Javaheri S, Servantes DM, Pelissari Kravchychyn AC, Almeida DR, Tufik S. In patients with heart failure, enhanced ventilatory response to exercise is associated with severe obstructive sleep apnea. J Clin Sleep Med. 2021;17(X):1875-1880.
© 2021 American Academy of Sleep Medicine.

Entities:  

Keywords:  enhanced ventilatory response; exercise; heart failure; obstructive sleep apnea

Mesh:

Year:  2021        PMID: 33949944      PMCID: PMC8636352          DOI: 10.5664/jcsm.9396

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.324


  29 in total

1.  Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure.

Authors:  D D Sin; F Fitzgerald; J D Parker; G Newton; J S Floras; T D Bradley
Journal:  Am J Respir Crit Care Med       Date:  1999-10       Impact factor: 21.405

2.  A new method for detecting anaerobic threshold by gas exchange.

Authors:  W L Beaver; K Wasserman; B J Whipp
Journal:  J Appl Physiol (1985)       Date:  1986-06

Review 3.  Concepts and applications of cardiopulmonary exercise testing.

Authors:  K T Weber; J S Janicki; P A McElroy; H K Reddy
Journal:  Chest       Date:  1988-04       Impact factor: 9.410

Review 4.  Apneas of Heart Failure and Phenotype-Guided Treatments: Part One: OSA.

Authors:  Shahrokh Javaheri; Lee K Brown; William T Abraham; Rami Khayat
Journal:  Chest       Date:  2019-04-29       Impact factor: 9.410

5.  Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis.

Authors:  P Ponikowski; D P Francis; M F Piepoli; L C Davies; T P Chua; C H Davos; V Florea; W Banasiak; P A Poole-Wilson; A J Coats; S D Anker
Journal:  Circulation       Date:  2001-02-20       Impact factor: 29.690

6.  Influence of obstructive sleep apnea on mortality in patients with heart failure.

Authors:  Hanqiao Wang; John D Parker; Gary E Newton; John S Floras; Susanna Mak; Kuo-Liang Chiu; Pimon Ruttanaumpawan; George Tomlinson; T Douglas Bradley
Journal:  J Am Coll Cardiol       Date:  2007-04-02       Impact factor: 24.094

Review 7.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

8.  Effects of short-term continuous positive airway pressure on myocardial sympathetic nerve function and energetics in patients with heart failure and obstructive sleep apnea: a randomized study.

Authors:  Allison B Hall; Maria C Ziadi; Judith A Leech; Shin-Yee Chen; Ian G Burwash; Jennifer Renaud; Robert A deKemp; Haissam Haddad; Lisa M Mielniczuk; Keiichiro Yoshinaga; Ann Guo; Li Chen; Olga Walter; Linda Garrard; Jean N DaSilva; John S Floras; Rob S B Beanlands
Journal:  Circulation       Date:  2014-07-03       Impact factor: 29.690

9.  Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure.

Authors:  Rami Khayat; William Abraham; Brian Patt; Vincent Brinkman; Jacob Wannemacher; Kyle Porter; David Jarjoura
Journal:  J Card Fail       Date:  2012-07       Impact factor: 5.712

10.  Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets.

Authors:  Danny J Eckert; David P White; Amy S Jordan; Atul Malhotra; Andrew Wellman
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

View more
  1 in total

1.  Effect of a Weight Loss and Lifestyle Intervention on Dietary Behavior in Men with Obstructive Sleep Apnea: The INTERAPNEA Trial.

Authors:  Almudena Carneiro-Barrera; Francisco J Amaro-Gahete; Lucas Jurado-Fasoli; Germán Sáez-Roca; Carlos Martín-Carrasco; Francisco J Tinahones; Jonatan R Ruiz
Journal:  Nutrients       Date:  2022-06-30       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.